Effects	O
of	O
pulmonary	B:C0024109
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
on	O
oxygen	O
impairment	O
during	O
cardiopulmonary	O
bypass	I:C0007202
for	O
stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
:	O
A	O
pilot	O
study	I:C0031928
.	O

Effects	O
of	O
pulmonary	O
static	B:C1283105
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
on	O
oxygen	O
impairment	O
during	O
cardiopulmonary	O
bypass	I:C0007202
for	O
stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
:	O
A	O
pilot	O
study	I:C0031928
.	O

Effects	O
of	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	B:C0043339
on	O
oxygen	O
impairment	O
during	O
cardiopulmonary	O
bypass	I:C0007202
for	O
stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
:	O
A	O
pilot	O
study	I:C0031928
.	O

Effects	O
of	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
on	O
oxygen	B:C0030054
impairment	O
during	O
cardiopulmonary	O
bypass	I:C0007202
for	O
stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
:	O
A	O
pilot	O
study	I:C0031928
.	O

Effects	O
of	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
on	O
oxygen	O
impairment	O
during	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
for	O
stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
:	O
A	O
pilot	O
study	I:C0031928
.	O

Effects	O
of	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
on	O
oxygen	O
impairment	O
during	O
cardiopulmonary	O
bypass	I:C0007202
for	O
stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
:	O
A	O
pilot	B:C0031928
study	I:C0031928
.	O

The	O
goal	B:C0018017
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
on	O
postoperative	O
oxygen	O
impairment	O
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
for	O
Stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
(	O
AAD	O
)	O
.	O

The	O
goal	O
of	O
this	O
study	B:C2603343
was	O
to	O
investigate	O
the	O
effects	O
of	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
on	O
postoperative	O
oxygen	O
impairment	O
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
for	O
Stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
(	O
AAD	O
)	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
pulmonary	B:C0024109
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
on	O
postoperative	O
oxygen	O
impairment	O
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
for	O
Stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
(	O
AAD	O
)	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
pulmonary	O
static	B:C1283105
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
on	O
postoperative	O
oxygen	O
impairment	O
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
for	O
Stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
(	O
AAD	O
)	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	B:C0043339
on	O
postoperative	O
oxygen	O
impairment	O
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
for	O
Stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
(	O
AAD	O
)	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
on	O
postoperative	O
oxygen	B:C0030054
impairment	O
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
for	O
Stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
(	O
AAD	O
)	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
on	O
postoperative	O
oxygen	O
impairment	O
during	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
(	O
cardiopulmonary	O
bypass	I:C0007202
)	O
for	O
Stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
(	O
AAD	O
)	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
on	O
postoperative	O
oxygen	O
impairment	O
during	O
cardiopulmonary	O
bypass	I:C0007202
(	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
)	O
for	O
Stanford	O
type	O
A	O
acute	O
aortic	O
dissection	O
(	O
AAD	O
)	O
.	O

This	O
prospective	O
single	B:C2985410
-	I:C2985410
center	I:C2985410
nonrandomized	I:C2985410
controlled	I:C2985410
clinical	I:C2985410
trial	I:C2985410
included	O
100	O
adult	O
patients	O
undergoing	O
surgery	O
for	O
Stanford	O
type	O
A	O
AAD	O
at	O
an	O
academic	O
hospital	I:C0000872
in	O
China	O
.	O

This	O
prospective	O
single	O
-	I:C2985410
center	I:C2985410
nonrandomized	I:C2985410
controlled	I:C2985410
clinical	I:C2985410
trial	I:C2985410
included	O
100	O
adult	O
patients	O
undergoing	O
surgery	B:C0543467
for	O
Stanford	O
type	O
A	O
AAD	O
at	O
an	O
academic	O
hospital	I:C0000872
in	O
China	O
.	O

This	O
prospective	O
single	O
-	I:C2985410
center	I:C2985410
nonrandomized	I:C2985410
controlled	I:C2985410
clinical	I:C2985410
trial	I:C2985410
included	O
100	O
adult	O
patients	O
undergoing	O
surgery	O
for	O
Stanford	O
type	O
A	O
AAD	O
at	O
an	O
academic	B:C0000872
hospital	I:C0000872
in	O
China	O
.	O

This	O
prospective	O
single	O
-	I:C2985410
center	I:C2985410
nonrandomized	I:C2985410
controlled	I:C2985410
clinical	I:C2985410
trial	I:C2985410
included	O
100	O
adult	O
patients	O
undergoing	O
surgery	O
for	O
Stanford	O
type	O
A	O
AAD	O
at	O
an	O
academic	O
hospital	I:C0000872
in	O
China	B:C0008115
.	O

Fifty	O
subjects	O
underwent	O
pulmonary	B:C0024109
static	O
inflation	I:C1283105
with	O
50	O
%	O
oxygen	O
from	O
January	O
2013	O
to	O
January	O
2014	O
,	O
and	O
50	O
underwent	O
inflation	O
with	O
50	O
%	O
xenon	O
from	O
January	O
2014	O
to	O
December	O
2014	O
.	O

Fifty	O
subjects	O
underwent	O
pulmonary	O
static	B:C1283105
inflation	I:C1283105
with	O
50	O
%	O
oxygen	O
from	O
January	O
2013	O
to	O
January	O
2014	O
,	O
and	O
50	O
underwent	O
inflation	O
with	O
50	O
%	O
xenon	O
from	O
January	O
2014	O
to	O
December	O
2014	O
.	O

Fifty	O
subjects	O
underwent	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
oxygen	B:C0030054
from	O
January	O
2013	O
to	O
January	O
2014	O
,	O
and	O
50	O
underwent	O
inflation	O
with	O
50	O
%	O
xenon	O
from	O
January	O
2014	O
to	O
December	O
2014	O
.	O

Fifty	O
subjects	O
underwent	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
oxygen	O
from	O
January	O
2013	O
to	O
January	O
2014	O
,	O
and	O
50	O
underwent	O
inflation	B:C1283105
with	O
50	O
%	O
xenon	O
from	O
January	O
2014	O
to	O
December	O
2014	O
.	O

Fifty	O
subjects	O
underwent	O
pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
oxygen	O
from	O
January	O
2013	O
to	O
January	O
2014	O
,	O
and	O
50	O
underwent	O
inflation	O
with	O
50	O
%	O
xenon	B:C0043339
from	O
January	O
2014	O
to	O
December	O
2014	O
.	O

During	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
,	O
the	O
lungs	O
were	O
inflated	O
with	O
either	O
50	O
%	O
xenon	O
(	O
xenon	O
group	O
)	O
or	O
50	O
%	O
oxygen	O
(	O
control	O
group	O
)	O
to	O
maintain	O
an	O
airway	O
pressure	I:C0428719
of	O
5	O
cm	O
H2O	O
.	O

During	O
cardiopulmonary	O
bypass	I:C0007202
,	O
the	O
lungs	B:C0024109
were	O
inflated	O
with	O
either	O
50	O
%	O
xenon	O
(	O
xenon	O
group	O
)	O
or	O
50	O
%	O
oxygen	O
(	O
control	O
group	O
)	O
to	O
maintain	O
an	O
airway	O
pressure	I:C0428719
of	O
5	O
cm	O
H2O	O
.	O

During	O
cardiopulmonary	O
bypass	I:C0007202
,	O
the	O
lungs	O
were	O
inflated	B:C1283105
with	O
either	O
50	O
%	O
xenon	O
(	O
xenon	O
group	O
)	O
or	O
50	O
%	O
oxygen	O
(	O
control	O
group	O
)	O
to	O
maintain	O
an	O
airway	O
pressure	I:C0428719
of	O
5	O
cm	O
H2O	O
.	O

During	O
cardiopulmonary	O
bypass	I:C0007202
,	O
the	O
lungs	O
were	O
inflated	O
with	O
either	O
50	O
%	O
xenon	B:C0043339
(	O
xenon	O
group	O
)	O
or	O
50	O
%	O
oxygen	O
(	O
control	O
group	O
)	O
to	O
maintain	O
an	O
airway	O
pressure	I:C0428719
of	O
5	O
cm	O
H2O	O
.	O

During	O
cardiopulmonary	O
bypass	I:C0007202
,	O
the	O
lungs	O
were	O
inflated	O
with	O
either	O
50	O
%	O
xenon	O
(	O
xenon	O
group	O
)	O
or	O
50	O
%	O
oxygen	B:C0030054
(	O
control	O
group	O
)	O
to	O
maintain	O
an	O
airway	O
pressure	I:C0428719
of	O
5	O
cm	O
H2O	O
.	O

During	O
cardiopulmonary	O
bypass	I:C0007202
,	O
the	O
lungs	O
were	O
inflated	O
with	O
either	O
50	O
%	O
xenon	O
(	O
xenon	O
group	O
)	O
or	O
50	O
%	O
oxygen	O
(	O
control	O
group	O
)	O
to	O
maintain	O
an	O
airway	B:C0428719
pressure	I:C0428719
of	O
5	O
cm	O
H2O	O
.	O

The	O
primary	O
outcome	O
was	O
oxygenation	B:C1278185
index	I:C1278185
(	O
oxygenation	O
index	I:C1278185
)	O
value	O
after	O
intubation	O
,	O
and	O
10	O
minutes	O
and	O
6	O
hours	O
after	O
the	O
operation	O
.	O

The	O
primary	O
outcome	O
was	O
oxygenation	O
index	I:C1278185
(	O
oxygenation	B:C1278185
index	I:C1278185
)	O
value	O
after	O
intubation	O
,	O
and	O
10	O
minutes	O
and	O
6	O
hours	O
after	O
the	O
operation	O
.	O

The	O
primary	O
outcome	O
was	O
oxygenation	O
index	I:C1278185
(	O
oxygenation	O
index	I:C1278185
)	O
value	O
after	O
intubation	B:C0021925
,	O
and	O
10	O
minutes	O
and	O
6	O
hours	O
after	O
the	O
operation	O
.	O

The	O
primary	O
outcome	O
was	O
oxygenation	O
index	I:C1278185
(	O
oxygenation	O
index	I:C1278185
)	O
value	O
after	O
intubation	O
,	O
and	O
10	O
minutes	O
and	O
6	O
hours	O
after	O
the	O
operation	B:C0543467
.	O

The	O
second	O
outcome	O
was	O
cytokine	B:C0079189
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
levels	O
after	O
intubation	O
and	O
10	O
minutes	O
,	O
6	O
hours	O
,	O
and	O
24	O
hours	O
after	O
the	O
operation	O
.	O

The	O
second	O
outcome	O
was	O
cytokine	O
and	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
levels	O
after	O
intubation	O
and	O
10	O
minutes	O
,	O
6	O
hours	O
,	O
and	O
24	O
hours	O
after	O
the	O
operation	O
.	O

The	O
second	O
outcome	O
was	O
cytokine	O
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
levels	O
after	O
intubation	B:C0021925
and	O
10	O
minutes	O
,	O
6	O
hours	O
,	O
and	O
24	O
hours	O
after	O
the	O
operation	O
.	O

The	O
second	O
outcome	O
was	O
cytokine	O
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
levels	O
after	O
intubation	O
and	O
10	O
minutes	O
,	O
6	O
hours	O
,	O
and	O
24	O
hours	O
after	O
the	O
operation	B:C0543467
.	O

Patients	O
treated	O
with	O
xenon	B:C0043339
had	O
lower	O
oxygenation	O
index	I:C1278185
levels	O
compared	O
to	O
the	O
control	O
group	O
before	O
surgery	O
(	O
P	O
=	O
0.002	O
)	O
;	O
however	O
,	O
there	O
was	O
no	O
difference	O
in	O
postoperative	O
values	O
between	O
the	O
2	O
groups	O
.	O

Patients	O
treated	O
with	O
xenon	O
had	O
lower	O
oxygenation	B:C1278185
index	I:C1278185
levels	O
compared	O
to	O
the	O
control	O
group	O
before	O
surgery	O
(	O
P	O
=	O
0.002	O
)	O
;	O
however	O
,	O
there	O
was	O
no	O
difference	O
in	O
postoperative	O
values	O
between	O
the	O
2	O
groups	O
.	O

Patients	O
treated	O
with	O
xenon	O
had	O
lower	O
oxygenation	O
index	I:C1278185
levels	O
compared	O
to	O
the	O
control	O
group	O
before	O
surgery	B:C0543467
(	O
P	O
=	O
0.002	O
)	O
;	O
however	O
,	O
there	O
was	O
no	O
difference	O
in	O
postoperative	O
values	O
between	O
the	O
2	O
groups	O
.	O

Following	O
surgery	B:C0543467
,	O
mean	O
maximal	O
oxygenation	O
index	I:C1278185
values	O
decreased	O
by	O
18.8	O
%	O
and	O
33.8	O
%	O
,	O
respectively	O
,	O
in	O
the	O
xenon	O
and	O
control	O
groups	O
.	O

Following	O
surgery	O
,	O
mean	O
maximal	O
oxygenation	B:C1278185
index	I:C1278185
values	O
decreased	O
by	O
18.8	O
%	O
and	O
33.8	O
%	O
,	O
respectively	O
,	O
in	O
the	O
xenon	O
and	O
control	O
groups	O
.	O

After	O
surgery	B:C0543467
,	O
the	O
levels	O
of	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
,	O
and	O
thromboxane	O
B2	I:C0040059
decreased	O
by	O
23.5	O
%	O
,	O
9.1	O
%	O
,	O
and	O
30.2	O
%	O
,	O
respectively	O
,	O
in	O
the	O
xenon	O
group	O
,	O
but	O
increased	O
by	O
10.8	O
%	O
,	O
26.2	O
%	O
,	O
and	O
26.4	O
%	O
,	O
respectively	O
,	O
in	O
the	O
control	O
group	O
.	O

After	O
surgery	O
,	O
the	O
levels	O
of	O
interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
,	O
and	O
thromboxane	O
B2	I:C0040059
decreased	O
by	O
23.5	O
%	O
,	O
9.1	O
%	O
,	O
and	O
30.2	O
%	O
,	O
respectively	O
,	O
in	O
the	O
xenon	O
group	O
,	O
but	O
increased	O
by	O
10.8	O
%	O
,	O
26.2	O
%	O
,	O
and	O
26.4	O
%	O
,	O
respectively	O
,	O
in	O
the	O
control	O
group	O
.	O

After	O
surgery	O
,	O
the	O
levels	O
of	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
)	O
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
,	O
and	O
thromboxane	O
B2	I:C0040059
decreased	O
by	O
23.5	O
%	O
,	O
9.1	O
%	O
,	O
and	O
30.2	O
%	O
,	O
respectively	O
,	O
in	O
the	O
xenon	O
group	O
,	O
but	O
increased	O
by	O
10.8	O
%	O
,	O
26.2	O
%	O
,	O
and	O
26.4	O
%	O
,	O
respectively	O
,	O
in	O
the	O
control	O
group	O
.	O

After	O
surgery	O
,	O
the	O
levels	O
of	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
,	O
tumor	B:C1456820
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
,	O
and	O
thromboxane	O
B2	I:C0040059
decreased	O
by	O
23.5	O
%	O
,	O
9.1	O
%	O
,	O
and	O
30.2	O
%	O
,	O
respectively	O
,	O
in	O
the	O
xenon	O
group	O
,	O
but	O
increased	O
by	O
10.8	O
%	O
,	O
26.2	O
%	O
,	O
and	O
26.4	O
%	O
,	O
respectively	O
,	O
in	O
the	O
control	O
group	O
.	O

After	O
surgery	O
,	O
the	O
levels	O
of	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
,	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
alpha	I:C1456820
,	O
and	O
thromboxane	B:C0040059
B2	I:C0040059
decreased	O
by	O
23.5	O
%	O
,	O
9.1	O
%	O
,	O
and	O
30.2	O
%	O
,	O
respectively	O
,	O
in	O
the	O
xenon	O
group	O
,	O
but	O
increased	O
by	O
10.8	O
%	O
,	O
26.2	O
%	O
,	O
and	O
26.4	O
%	O
,	O
respectively	O
,	O
in	O
the	O
control	O
group	O
.	O

Moreover	O
,	O
IL	B:C0085295
-	I:C0085295
10	I:C0085295
levels	O
increased	O
by	O
28	O
%	O
in	O
the	O
xenon	O
group	O
and	O
decreased	O
by	O
7.5	O
%	O
in	O
the	O
control	O
group	O
.	O

There	O
were	O
significant	O
time	O
and	O
treatment	B:C0087111
-	O
time	O
interaction	O
effects	O
on	O
methane	O
dicarboxylic	I:C0574031
aldehyde	I:C0574031
(	O
P	O
=	O
0.000	O
and	O
P	O
=	O
0.050	O
,	O
respectively	O
)	O
and	O
myeloperoxidase	O
(	O
P	O
=	O
0.000	O
and	O
P	O
=	O
0.001	O
in	O
xenon	O
and	O
control	O
groups	O
,	O
respectively	O
)	O
.	O

There	O
were	O
significant	O
time	O
and	O
treatment	O
-	O
time	O
interaction	O
effects	O
on	O
methane	B:C0574031
dicarboxylic	I:C0574031
aldehyde	I:C0574031
(	O
P	O
=	O
0.000	O
and	O
P	O
=	O
0.050	O
,	O
respectively	O
)	O
and	O
myeloperoxidase	O
(	O
P	O
=	O
0.000	O
and	O
P	O
=	O
0.001	O
in	O
xenon	O
and	O
control	O
groups	O
,	O
respectively	O
)	O
.	O

There	O
were	O
significant	O
time	O
and	O
treatment	O
-	O
time	O
interaction	O
effects	O
on	O
methane	O
dicarboxylic	I:C0574031
aldehyde	I:C0574031
(	O
P	O
=	O
0.000	O
and	O
P	O
=	O
0.050	O
,	O
respectively	O
)	O
and	O
myeloperoxidase	B:C0027021
(	O
P	O
=	O
0.000	O
and	O
P	O
=	O
0.001	O
in	O
xenon	O
and	O
control	O
groups	O
,	O
respectively	O
)	O
.	O

Pulmonary	B:C0024109
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
during	O
cardiopulmonary	O
bypass	I:C0007202
could	O
attenuate	O
oxygenation	O
index	I:C1278185
decreases	O
at	O
the	O
end	O
of	O
surgery	O
for	O
Stanford	O
type	O
A	O
AAD	O
.	O

Pulmonary	O
static	B:C1283105
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
during	O
cardiopulmonary	O
bypass	I:C0007202
could	O
attenuate	O
oxygenation	O
index	I:C1278185
decreases	O
at	O
the	O
end	O
of	O
surgery	O
for	O
Stanford	O
type	O
A	O
AAD	O
.	O

Pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	B:C0043339
during	O
cardiopulmonary	O
bypass	I:C0007202
could	O
attenuate	O
oxygenation	O
index	I:C1278185
decreases	O
at	O
the	O
end	O
of	O
surgery	O
for	O
Stanford	O
type	O
A	O
AAD	O
.	O

Pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
during	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
could	O
attenuate	O
oxygenation	O
index	I:C1278185
decreases	O
at	O
the	O
end	O
of	O
surgery	O
for	O
Stanford	O
type	O
A	O
AAD	O
.	O

Pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
during	O
cardiopulmonary	O
bypass	I:C0007202
could	O
attenuate	O
oxygenation	B:C1278185
index	I:C1278185
decreases	O
at	O
the	O
end	O
of	O
surgery	O
for	O
Stanford	O
type	O
A	O
AAD	O
.	O

Pulmonary	O
static	O
inflation	I:C1283105
with	O
50	O
%	O
xenon	O
during	O
cardiopulmonary	O
bypass	I:C0007202
could	O
attenuate	O
oxygenation	O
index	I:C1278185
decreases	O
at	O
the	O
end	O
of	O
surgery	B:C0543467
for	O
Stanford	O
type	O
A	O
AAD	O
.	O

Thus	O
,	O
xenon	B:C0043339
may	O
function	O
by	O
triggering	O
anti-inflammatory	O
responses	O
and	O
suppressing	O
pro-inflammatory	O
and	O
oxidative	O
effects	O
.	O

